VOLUME 14, ISSUE 5 / MARCH 2022
Preliminary Communication
FEBRUARY 2022
Monitoring of hemoglobin and erythropoiesis-related mRNA with dried blood spots in athletes and patients
- Francesco Loria
, - Andreas P Stutz,
- Angela Rocca,
- Silke Grabherr,
- Tiia Kuuranne,
- Menno Pruijm &
- Nicolas Leuenberger
- Pages:241–251
- Published Online:17 February 2022
Methodology
FEBRUARY 2022
Development and validation of an LC-MS/MS method for determination of a novel anticancer agent (CPI-613) in human plasma
- Nageswara Rao Reddy ,
- Vijay Reddy,
- Asela Boteju,
- Lakmal Boteju,
- Troy Voelker,
- Sherry Liu &
- Ke Hu
- Pages:253–266
- Published Online:17 February 2022
Methodology
FEBRUARY 2022
Simultaneous measurement of mouse and human albumin in chimeric mice with humanized livers
- France Landry,
- Hong Shen,
- Yueping Zhang,
- Asako Uchiyama,
- Yoshinari Miyata,
- Yoshio Morikawa,
- Beth Joshi &
- Petia Shipkova
- Pages:267–278
- Published Online:23 February 2022
FEBRUARY 2022
Comparison of three parallelism assessment methods of biomarker quantification by LC-MS/MS: a case study of the bioanalysis of creatinine in human urine samples
- Xiazi I Qiu ,
- John P Savaryn,
- Kenneth J Ruterbories,
- Qin C Ji &
- Gary Jenkins
- Pages:279–287
- Published Online:21 February 2022
Research Article
FEBRUARY 2022
Lysosphingolipid urine screening test using mass spectrometry for the early detection of lysosomal storage disorders
- Marcel A Kelkel ,
- Michel Boutin ,
- Filipa Curado,
- Peter Bauer,
- Éliane Beauregard-Lacroix,
- François E Mercier,
- Bruno Maranda,
- Iskren Menkovic,
- Tristan Martineau &
- Christiane Auray-Blais
- Pages:289–306
- Published Online:4 February 2022